Literature DB >> 18312938

Altered antioxidant capacity in human renal cell carcinoma: role of glutathione associated enzymes.

Marija Pljesa-Ercegovac1, Jasmina Mimic-Oka, Dejan Dragicevic, Ana Savic-Radojevic, Marija Opacic, Steva Pljesa, Radoslav Radosavljevic, Tatjana Simic.   

Abstract

PURPOSE: We aimed to discern the role of glutathione (GSH) associated enzymes in maintaining high GSH levels in renal cell carcinoma (RCC) of the clear cell type and analyze RCC enzyme antioxidant capacity. Since changes in cellular redox balance in RCC might also be related to alterations of glutathione S-transferase (GST) phenotype, GST class alpha and pi expression was also explored. METHODS AND MATERIALS: Human kidney specimens of tumor and distant nontumor regions were obtained from 15 patients with RCC at the time of surgery. The activities of GSH-replenishing enzymes, gamma-glutamylcysteine synthetase (gamma-GCS), gamma-glutamyl transferase (gamma-GT), and glutathione reductase (GR), as well as the activities of antioxidant enzymes glutathione peroxidase (GPX) and catalase (CAT) were determined spectrophotometrically. GST alpha and pi class expression was determined by immunoblot.
RESULTS: In the course of renal cancerization, significant changes appear in the activities of GSH-replenishing and antioxidant enzymes. The activity of the key enzyme of GSH synthesis, gamma-GCS, is up-regulated (P < 0.001), while the activities of gamma-GT and GR are down-regulated in renal tumors compared to nontumor tissue (P < 0.001 and P < 0.05, respectively). Activities of GPX and CAT were also down-regulated (P < 0.001 and P < 0.05, respectively) in RCC. Changes in enzyme antioxidant capacity in RCC were associated with decreased GST class alpha (P < 0.001) and unchanged GST pi expression at the protein level.
CONCLUSIONS: Changes in redox status in RCC as a consequence of decreased enzyme antioxidant capacity, together with altered GST alpha expression, may be important factors in development and tumor growth. The up-regulation of gamma-GCS and high levels of GSH in RCC may be an attempt to limit injury caused by oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18312938     DOI: 10.1016/j.urolonc.2007.02.007

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  16 in total

1.  Ectopic expression of human MutS homologue 2 on renal carcinoma cells is induced by oxidative stress with interleukin-18 promotion via p38 mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase (JNK) signaling pathways.

Authors:  Chen Mo; Yumei Dai; Ning Kang; Lianxian Cui; Wei He
Journal:  J Biol Chem       Date:  2012-04-09       Impact factor: 5.157

Review 2.  Redox-modulated phenomena and radiation therapy: the central role of superoxide dismutases.

Authors:  Aaron K Holley; Lu Miao; Daret K St Clair; William H St Clair
Journal:  Antioxid Redox Signal       Date:  2014-02-14       Impact factor: 8.401

Review 3.  Glutathione S-transferases in kidney and urinary bladder tumors.

Authors:  Tatjana Simic; Ana Savic-Radojevic; Marija Pljesa-Ercegovac; Marija Matic; Jasmina Mimic-Oka
Journal:  Nat Rev Urol       Date:  2009-05       Impact factor: 14.432

4.  Doxorubicin toxicity can be ameliorated during antioxidant L-carnitine supplementation.

Authors:  Othman A Alshabanah; Mohamed M Hafez; Mohamed M Al-Harbi; Zeinab K Hassan; Salim S Al Rejaie; Yosef A Asiri; Mohamed M Sayed-Ahmed
Journal:  Oxid Med Cell Longev       Date:  2010-11-01       Impact factor: 6.543

5.  Evaluation of oxidative stress status and antioxidant capacity in patients with renal cell carcinoma.

Authors:  Mustafa Aldemir; Ersagun Karaguzel; Emrah Okulu; Ahmet Gudeloglu; Kemal Ener; Asim Ozayar; Ozcan Erel
Journal:  Cent European J Urol       Date:  2015-11-23

6.  Different effects of H2O2 treatment on cervical squamous carcinoma cells and adenocarcinoma cells.

Authors:  Peihai Zhang; Haiqin Yin; Sie Wang; Yuping Wei; Nan Peng; Wenxiang Bi; Xiaoyuan Wang
Journal:  Arch Med Sci       Date:  2015-12-11       Impact factor: 3.318

7.  A novel functional polymorphism of GSTM3 reduces clear cell renal cell carcinoma risk through enhancing its expression by interfering miR-556 binding.

Authors:  Ying Wang; Zi-Ying Yang; Yi-Huan Chen; Feng Li; Han Shen; You Yu; Hao-Yue Huang; Zhen-Ya Shen
Journal:  J Cell Mol Med       Date:  2018-03-22       Impact factor: 5.310

Review 8.  The peroxisome: an update on mysteries 2.0.

Authors:  Markus Islinger; Alfred Voelkl; H Dariush Fahimi; Michael Schrader
Journal:  Histochem Cell Biol       Date:  2018-09-15       Impact factor: 4.304

9.  Combined GSTM1-Null, GSTT1-Active, GSTA1 Low-Activity and GSTP1-Variant Genotype Is Associated with Increased Risk of Clear Cell Renal Cell Carcinoma.

Authors:  Vesna M Coric; Tatjana P Simic; Tatjana D Pekmezovic; Gordana M Basta-Jovanovic; Ana R Savic Radojevic; Sanja M Radojevic-Skodric; Marija G Matic; Dejan P Dragicevic; Tanja M Radic; Ljiljana M Bogdanovic; Zoran M Dzamic; Marija S Pljesa-Ercegovac
Journal:  PLoS One       Date:  2016-08-08       Impact factor: 3.240

10.  The SOD Mimic MnTnHex-2-PyP5+ Reduces the Viability and Migration of 786-O Human Renal Cancer Cells.

Authors:  João G Costa; Nuno Saraiva; Ines Batinic-Haberle; Matilde Castro; Nuno G Oliveira; Ana S Fernandes
Journal:  Antioxidants (Basel)       Date:  2019-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.